[Funding Alert] Ensuredit Raises INR 2.5 Cr In Pre-Series A Funding Led By Venture Catalysts

The platform aims to leverage the capital infusion to establish its position as a market leader by bolstering its tech infrastructure and outreach

Free Book Preview Money-Smart Solopreneur

This book gives you the essential guide for easy-to-follow tips and strategies to create more financial success.

2 min read

Opinions expressed by Entrepreneur contributors are their own.

You’re reading Entrepreneur India, an international franchise of Entrepreneur Media.

Venture Catalysts has announced on Wednesday to have led an INR 2.5 crore pre-Series A investment in Ensuredit, an insurance technology startup. Leveraging its platform-as-a-service business model, the platform is committed to helping brokers, corporate agents, and insurers to bolster their revenue generation.


Founded in 2019 by Amit Boni, Rohit Sadhu, and Vikas Ranga, the platform aims to disrupt the insurance industry in India and unlock the next chapter of its development by utilizing the power of technology. 


To achieve this,

Read More

Algorithmic Trading Platform Algobulls Raises Undisclosed Amount From Venture Catalysts

The fresh capital will be used for setting up teams in various divisions and to scale its operation in foreign lands

Grow Your Business, Not Your Inbox

Stay informed and join our daily newsletter now!

2 min read

You’re reading Entrepreneur India, an international franchise of Entrepreneur Media.

Venture Catalysts, an integrated incubator and accelerator, on Tuesday announced that it has led an undisclosed amount in AlgoBulls, an algorithmic trading platform.

Mumbai-based Algobulls was founded by Pushpak Dagade, Jimmit Patel and Suraj Bathija last year, and claims to provide a 100 per cent automated, customized, and professional experience of trading in stock markets to all. Leveraging algorithm, the startup imparts required information to people to trade and clinch profit. It boasts of providing an end-to-end  solution to its users with ready-to-use strategies and market knowledge in an automated form without requiring any manual intervention.

Commenting on the

Read More

Near-Term Catalysts to Watch for COVID Vaccine Stocks

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have reported great efficacy results for their coronavirus vaccine candidate BNT162b2. Moderna (NASDAQ:MRNA) announced outstanding efficacy results for its experimental vaccine mRNA-1273. What are the next near-term catalysts for investors to look for? Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights answer that question in this Motley Fool Live video recorded on Nov. 16, 2020.

Corinne Cardina: So what are some near-term catalysts that investors should be keeping an eye on? What kind of articles are you planning in the next week is what I should be asking, because I know you’re keeping an eye on everything.

Keith Speights: Yeah. Near-term catalysts, the obvious ones are emergency use authorization filings by Pfizer and by Moderna. Pfizer’s should come this week. Either this week, I would say at least by next week. But they were saying third week of November, and if

Read More

Ultrafast laser experiments pave way to better industrial catalysts — ScienceDaily

Arizona State University’s Scott Sayres and his team have recently published an ultrafast laser study on uncharged iron oxide clusters, which could ultimately lead to the development of new and less-expensive industrial catalysts. It might also contribute to a better understanding of the universe since iron oxides are observed in the emission spectra of stars.

Sayres is an assistant professor in ASU’s School of Molecular Sciences and a faculty member in the Biodesign Institute’s Center for Applied Structural Discovery.

Most chemical industries utilize catalysts to enhance the rate of reaction and selectivity in obtaining their desired products. For example, catalytic converters in the exhausts of our vehicles commonly use platinum, palladium and rhodium to help break down pollutants.

All three of these metals are significantly more expensive than gold, which is in turn a lot more costly than iron. On average a catalytic converter costs $1,000 but can be as

Read More

General Catalyst’s SPAC Health Assurance Acquisition files for a $500 million IPO

Health Assurance Acquisition, a blank check company formed by General Catalyst targeting healthcare technology, filed on Monday with the SEC to raise up to $500 million in an initial public offering.

The Cambridge, MA-based company plans to raise $500 million by offering 50 million units, which the company calls SAIL (Stakeholder Aligned Initial Listing) securities, at a price of $10. Each SAIL security consists of one share of common stock and one-quarter of a warrant, exercisable at $11.50. At the proposed deal size, Health Assurance Acquisition would command a market value of $525 million. Sponsor General Catalyst and an affiliated charitable foundation will receive a promote of only 5%, with additional “alignment shares” rewarded for outsized post-merger returns over a series of years.

The company is led by CEO and Chairman Hemant Teneja, who is a Managing Partner at General Catalyst Partners and serves on the boards of

Read More